NEWS8 January 2013
UK — Bob Douglas, formerly Ipsos Healthcare’s global head of custom research, has joined P\S\L Group as chief strategy officer.
Douglas was global head of healthcare for Synovate prior to its takeover by Ipsos in 2011, after which he took the top custom research job in the merged healthcare teams.
Prior to Synovate he was head of international research at TNS Healthcare and has worked clientside with Boehringer Ingelheim, Wellcome and Hoffmann-La Roche.
On joining P\S\L, Douglas said: “As a privately-held organisation, [P\S\L’s] commitment to long-term value creation is not compromised by the short-term requirements of public or private equity shareholders.”